Cyclerion receives FDA feedback on depression treatment study

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/28/2026

1. SPY
2. CDNS
3. NVDA
4. AAPL
5. USO
6. META
7. FFIV
8. TFII
9. XFLT
10. AMZN

Go back to Cyclerion receives FDA feedback on depression treatment study
(NASDAQ: CYCN) Delayed: 3.50 --0 (-0%)
Previous Close $3.50    52 Week High $ 
Open $3.50    52 Week Low $ 
Day High $3.66    P/E N/A 
Day Low $3.37    EPS $ 
Volume 18,507